Search Results - "Zendehrokh, Nooreldin"

Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer by Nodin, Björn, Zendehrokh, Nooreldin, Sundström, Magnus, Jirström, Karin

“…Activating KRAS mutations are common in ovarian carcinomas of low histological grade, less advanced clinical stage and mucinous histological subtype, and form…”
Get full text

Liquid-based cytology using cytorich red/tripath is diagnostically equivalent to conventional smears for bronchial washings and brushings and reduces the cost by Zendehrokh, Nooreldin, Olejnicka, Beata, Westman, Agneta, Dejmek, Annika

“…A split sample study was performed on 109 bronchial brushings and washings and evaluated from conventional slides (CS) and CytoRich Red/Tripath preparations…”
Get full text

Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival by Nodin, Björn, Zendehrokh, Nooreldin, Brändstedt, Jenny, Nilsson, Elise, Manjer, Jonas, Brennan, Donal J, Jirström, Karin

“…Altered androgen hormone homeostasis and androgen receptor (AR) activity have been implicated in ovarian carcinogenesis but the relationship between AR…”
Get full text

Preparation of DNA from cytological material by Dejmek, Annika, Zendehrokh, Nooreldin, Tomaszewska, Malgorzata, Edsjö, Anders

“…BACKGROUND Personalized oncology requires molecular analysis of tumor cells. Several studies have demonstrated that cytological material is suitable for DNA…”
Get full text

Preparation of DNA From Cytological Material: Effects of Fixation, Staining, and Mounting Medium on DNA Yield and Quality by DEJMEK, Annika, ZENDEHROKH, Nooreldin, TOMASZEWSKA, Malgorzata, EDSJÖ, Anders

“…Personalized oncology requires molecular analysis of tumor cells. Several studies have demonstrated that cytological material is suitable for DNA analysis, but…”
Get full text

Mutation in Kras Codon 13, but not in Codon 12, Correlates with Poor Prognosis in Colorectal Cancer: a Cohort Study by Wangefjord, Sakarias, Zendehrokh, Nooreldin, Nodin, Björn, Sundström, Magnus, Jirström, Karin, Eberhard, Jakob

Get full text

Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study by Wangefjord, Sakarias, Sundström, Magnus, Zendehrokh, Nooreldin, Lindquist, Kajsa Ericson, Nodin, Björn, Jirström, Karin, Eberhard, Jakob

“…Activating KRAS and BRAF mutations predict unresponsiveness to EGFR-targeting therapies in colorectal cancer (CRC), but their prognostic value needs further…”
Get full text

High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer by Hjelm, Barbara, Brennan, Donal J., Zendehrokh, Nooreldin, Eberhard, Jakob, Nodin, Björn, Gaber, Alexander, Pontén, Fredrik, Johannesson, Henrik, Smaragdi, Kristina, Frantz, Christian, Hober, Sophia, Johnson, Louis B., Påhlman, Sven, Jirström, Karin, Uhlen, Mathias

“…Purpose: In this study, we investigated the prognostic impact of human RBM3 expression in colorectal cancer using tissue microarray‐based immunohistochemical…”
Get full text

Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes by Zendehrokh, Nooreldin, Dejmek, Annika

“…Telomerase Repeat Amplification Protocol (TRAP) in situ was performed on cytospin preparations from 65 effusions from the serous cavities (45 pleural and 19…”
Get full text

Comparison of Liquid-Based Cytology and Conventional Filter Preparations in Urine: A Possible Serious Pitfall by Losell, Karin, Zendehrokh, Nooreldin, Solding, Inger, Dejmek, Annika

Get full text

Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay by Hansson, Maire, Zendehrokh, Nooreldin, Ohyashiki, Junko, Ohyashiki, Kazuma, Westman, Ulla-Britt, Roos, Göran, Dejmek, Annika

“…We previously found telomere repeat amplification protocol (TRAP) in situ helpful in the diagnosis of malignancy in effusions, whereas varying sensitivities…”
Get full text

Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions by Rehnberg, Johanna, Zendehrokh, Nooreldin, Dejmek, Annika

“…To determine the proliferation rates of mesothelial cells in metastatic and benign effusions. Immunohistochemistry was performed on formalin-fixed pellets from…”
Get more information

Weak Telomerase Activity in Malignant Cells in Metastatic Serous Effusions by Zendehrokh, Nooreldin, Franzen, Lina, Dejmek, Annika

Get full text

Comparison of NCL-hTERT Antibody Reactivity and Telomere Repeat Amplification Protocol in Situ in Effusions by Zendehrokh, Nooreldin, Rehnberg, Johanna, Dejmek, Annika

“…To compare the performances of 2 methods, telomerase repeat amplification protocol (TRAP) in situ and antibodies to the hTERT protein, in assessing telomerase…”
Get full text

Weak telomerase activity in malignant cells in metastatic serous effusions : Correlation to short survival time by ZENDEHROKH, Nooreldin, FRANZEN, Lina, DEJMEK, Annika

“…The purpose of this study was to evaluate whether the intensity of telomerase activity measured on the cellular level in effusions correlates to survival time…”
Get full text

Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay by Hansson, Maire, Zendehrokh, Nooreldin, Ohyashiki, Junko, Ohyashiki, Kazuma, Westman, Ulla-Britt, Roos, Göran, Dejmek, Annika

“…CONTEXTWe previously found telomere repeat amplification protocol (TRAP) in situ helpful in the diagnosis of malignancy in effusions, whereas varying…”
Get full text